Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DCD III Study: a Multicentre Prospective Study to Identify Parameters Predicting Time to Death in Controlled Circulatory Death (cDCD) Donors and Prospective Validation of Previous Derived Prediction Models on Time to Death.

NCT04123275 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04123275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04123275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DCD III Study: a Multicentre Prospective Study to Identify Parameters Predicting Time to Death in Controlled Circulatory Death (cDCD) Donors and Prospective Validation of Previous Derived Prediction Models on Time to Death.
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
July 7, 2015
Completion date
October 31, 2018
Enrollment
400 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

tissue and organ procurement